MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2004

[A novel approach to HLA-mismatched transplantation].

Huang Xiao-jun, Han Wei, Xu Lan-ping, Chen Huan, Liu Dai-hong, Chen Yu-hong, Jiang Qian, Lu Jin, Liu Kai-yan, Ren Han-yun, Lu Dao-pei

Аннотация на английскомСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To investigate the new methods of human leukocyte antigen (HLA) mismatched transplantation in patients with hematologic malignancies.

METHODS

In this pilot study, 58 patients, 33 with high-risk or advanced leukemia, were transplanted with cells from an HLA-haploidentical family donor with at least 1 of 6 loci mismatched. After conditioning, patients received non ex vivo, T cell-depleted grafts of G-CSF-primed bone marrow plus G-CSF-mobilized peripheral blood stem cells, as well as graft-versus-host-disease (GVHD) prophylaxis.

RESULTS

All patients achieved sustained, full donor type engraftment. The incidence of grades II-IV acute GVHD was 37.9% (22 of 58), and grades III and IV aGVHD developed in only 2 and 1 patients, respectively. Furthermore, there was no statistically significant association between the extents of HLA mismatching and the degree of aGVHD. Twenty six of 42 (61.9%) evaluable patients had developed chronic GVHD (cGVHD) with limited cGVHD in 15. Nine patients relapsed, all but one with advanced or refractory leukemia. Fourteen patients died (24.1%), of whom 7 died of recurrent diseases and 7 of transplant-related complications (TRM): main causes of TRM were infection(2), intestinal pneumonia(2), CMV encephalitis(1), hepatitis(1) and aGVHD (1). Forty-four of the 58 patients (75.9%) survived and 42 (72.4%) were disease free with a median follow-up of 10 months (range, 2 to 37.5 months). The 2-year probabilities of disease-free survival for patients with standard and high risks were 77.6% and 63.2% respectively, which showed that high-risk disease status at transplantation was associated with worse disease-free survival (P=0.04). The degree of HLA mismatching between the donor and the recipient was not related to event-free survival (P=0.57), nor was cell number infused and aGVHD (P=0.78, 0.94 respectively).

CONCLUSION

(1)HLA mismatched transplantation can be per formed without ex vivo T cell depletion. (2)Using G CSF mobilized PBSCs as a source of stem cells may be possible and safe even in HLA mismatched transplantation.

Для цитирования: Huang Xiao-jun, Han Wei, Xu Lan-ping, Chen Huan, Liu Dai-hong, Chen Yu-hong, Jiang Qian, Lu Jin, Liu Kai-yan, Ren Han-yun, Lu Dao-pei. [A novel approach to HLA-mismatched transplantation].. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences. 2004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.